242 related articles for article (PubMed ID: 8169787)
1. Safety of oral cyclodextrins: effects of hydroxypropyl cyclodextrins, cyclodextrin sulfates and cationic cyclodextrins on steroid balance in rats.
Gerloczy A; Hoshino T; Pitha J
J Pharm Sci; 1994 Feb; 83(2):193-6. PubMed ID: 8169787
[TBL] [Abstract][Full Text] [Related]
2. Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.
Irie T; Fukunaga K; Garwood MK; Carpenter TO; Pitha J; Pitha J
J Pharm Sci; 1992 Jun; 81(6):524-8. PubMed ID: 1522488
[TBL] [Abstract][Full Text] [Related]
3. Bile acid and sterol solubilization in 2-hydroxypropyl-beta-cyclodextrin.
De Caprio J; Yun J; Javitt NB
J Lipid Res; 1992 Mar; 33(3):441-3. PubMed ID: 1569391
[TBL] [Abstract][Full Text] [Related]
4. Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.
Irie T; Fukunaga K; Pitha J
J Pharm Sci; 1992 Jun; 81(6):521-3. PubMed ID: 1522487
[TBL] [Abstract][Full Text] [Related]
5. Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles.
Pitha J; Gerloczy A; Olivi A
J Pharm Sci; 1994 Jun; 83(6):833-7. PubMed ID: 9120816
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexation of the sunscreen agent 2-ethylhexyl-p-dimethylaminobenzoate with hydroxypropyl-beta-cyclodextrin: effect on photostability.
Scalia S; Villani S; Casolari A
J Pharm Pharmacol; 1999 Dec; 51(12):1367-74. PubMed ID: 10678490
[TBL] [Abstract][Full Text] [Related]
7. Impact of beta-cyclodextrin and resistant starch on bile acid metabolism and fecal steroid excretion in regard to their hypolipidemic action in hamsters.
Trautwein EA; Forgbert K; Rieckhoff D; Erbersdobler HF
Biochim Biophys Acta; 1999 Jan; 1437(1):1-12. PubMed ID: 9931405
[TBL] [Abstract][Full Text] [Related]
8. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
[TBL] [Abstract][Full Text] [Related]
9. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
Abe K; Irie T; Uekama K
Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrin derivatives in pharmaceutics.
Albers E; Müller BW
Crit Rev Ther Drug Carrier Syst; 1995; 12(4):311-37. PubMed ID: 9501966
[TBL] [Abstract][Full Text] [Related]
11. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
[TBL] [Abstract][Full Text] [Related]
12. Complexation of butylbenzenes with 2-hydroxypropyl-cyclodextrins in aqueous solution.
Saito Y; Hashizaki K; Taguchi H; Ogawa N
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2003 May; 38(5):771-7. PubMed ID: 12744431
[TBL] [Abstract][Full Text] [Related]
13. Safety of parenteral hydroxypropyl beta-cyclodextrin.
Carpenter TO; Gerloczy A; Pitha J
J Pharm Sci; 1995 Feb; 84(2):222-5. PubMed ID: 7738806
[TBL] [Abstract][Full Text] [Related]
14. Improved assay of hepatic microsomal cholesterol 7 alpha-hydroxylase activity by the use of hydroxypropyl-beta-cyclodextrin and an NADPH-regenerating system.
Souidi M; Parquet M; Lutton C
Clin Chim Acta; 1998 Jan; 269(2):201-17. PubMed ID: 9526678
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary beta-cyclodextrin in hypercholesterolaemic rats.
García-Mediavilla V; Villares C; Culebras JM; Báyon JE; González-Gallego J
Pharmacol Toxicol; 2003 Feb; 92(2):94-9. PubMed ID: 12747579
[TBL] [Abstract][Full Text] [Related]
16. Hydroxypropyl-beta-cyclodextrin enhanced fluorimetric method for the determination of melatonin and 5-methoxytryptamine.
Galian RE; Veglia AV; de Rossi RH
Analyst; 2000 Aug; 125(8):1465-70. PubMed ID: 11002929
[TBL] [Abstract][Full Text] [Related]
17. Complexation of steroid hormones with cyclodextrin derivatives: substituent effects of the guest molecule on solubility and stability in aqueous solution.
Albers E; Müller BW
J Pharm Sci; 1992 Aug; 81(8):756-61. PubMed ID: 1403720
[TBL] [Abstract][Full Text] [Related]
18. A convenient synthesis of 7 alpha-hydroxycholest-4-en-3-one by the hydroxypropyl-beta-cyclodextrin-facilitated cholesterol oxidase oxidation of 3 beta,7 alpha-cholest-5-ene-3,7-diol.
Alexander DL; Fisher JF
Steroids; 1995 Mar; 60(3):290-4. PubMed ID: 7792834
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat.
Frijlink HW; Visser J; Hefting NR; Oosting R; Meijer DK; Lerk CF
Pharm Res; 1990 Dec; 7(12):1248-52. PubMed ID: 2095562
[TBL] [Abstract][Full Text] [Related]
20. Nutritional effects of cyclodextrins on liver and serum lipids and cecal organic acids in rats.
Kaewprasert S; Okada M; Aoyama Y
J Nutr Sci Vitaminol (Tokyo); 2001 Oct; 47(5):335-9. PubMed ID: 11814148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
